Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2012, Vol. 10 ›› Issue (7): 793-799.doi: 10.3736/jcim20120710

• Original Experimental Research • Previous Articles     Next Articles

Effects of ursolic acid in ameliorating insulin resistance in liver of KKAy mice via peroxisome proliferator-activated receptors α and γ

Lin Wang1, Guan-liang Wang1, Jia-han Liu1, Di Li1, De-zeng Zhu1(), Liang-neng Wu2()   

  1. 1. Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, China
    2. School of Traditional Chinese Medicine, Second Military Medical University, Shanghai 200433, China
  • Received:2011-12-19 Accepted:2012-01-28 Online:2012-07-20 Published:2018-07-15
  • Contact: De-zeng Zhu,Liang-neng Wu E-mail:zdzzyx@163.com;wuliangnen@sina.com

Objective: To explore the effects and mechanism of ursolic acid in improving hepatic insulin resistance in KKAy mice with spontaneous type 2 diabetes.
Methods: Thirty-five KKAy mice were divided into five groups according to the randomized block design, namely, control, rosiglitazone, fenofibrate, and high- and low-dose ursolic acid groups with seven mice in each group. C57BL/6J mice were used as the normal control group. At the end of the 4th week, free fatty acid (FFA), tumor necrosis factor-α (TNF-α) and adiponectin contents in serum were detected by enzyme-linked immunosorbent assay; the protein expressions of phosphoenolpyruvate carboxykinase (PEPCK), insulin receptor substrate-2 (IRS-2) and glucose transport factor-2 (GLUT-2) were detected by Western blot method; the mRNA expressions of PEPCK, IRS-2 and GLUT-2 were detected by real-time polymerase chain reaction; the expressions of peroxisome proliferator-activated receptor α (PPARα) and peroxisome proliferator-activated receptor γ (PPARγ) in liver tissue were detected by immunohistochemical method.
Results: After four weeks of intervention, the contents of FFA, TNF-α and adiponectin in serum of the high-dose ursolic acid group had changed, showing statistically significant difference compared to those of the control group (P<0.01); high dose of ursolic acid had depressant effect on the expressions of PEPCK protein and PEPCK mRNA (P<0.01); low dose of ursolic acid depressed the expression of PEPCK mRNA and induced phosphorylation of IRS-2 in the liver (P<0.05); both high and low dose of ursolic acid improved the expression of PPARα in the liver (P<0.01).
Conclusion: The effects of ursolic acid in improving hepatic insulin resistance in KKAy mice with spontaneous type 2 diabetes may be closely related to affecting the contents of FFA, TNF-α and adiponectin, improving the expression of PPARα protein, regulating transcription of PEPCK protein and inducing phosphorylation of IRS-2.

Key words: hypoglycemic agents (TCD), ursolic acid, PPARα, PPARγ, insulin resistance, diabetes mellitus, experimental, procetofen, mice

Table 1

Levels of serum FFA, TNF-α and adiponectin in different groups (x±s)"

Group n FFA (μmol/L) TNF-α (ng/L) Adiponectin (mg/L)
Normal 7 74.33±7.69**△△▲▲ 78.64±1.16** 19.52±0.09**△△
Control 7 427.32±9.31▲▲ 133.45±1.60△△ 4.13±0.12▲▲
Rosiglitazone 7 352.68±9.15▲▲ 92.74±1.86** 6.77±0.06*
Fenofibrate 6 192.54±85.48**△△ 103.85±1.61** 10.19±0.37**△
UA 300 mL/(kg·d) 7 250.29±8.08*△ 105.42±1.27* 6.82±0.10
UA 150 mL/(kg·d) 6 341.45±151.41▲▲ 131.85±1.97△△ 5.79±0.05

Figure 1

IRS-2 phosphorylation and expressions of PEPCK and GLUT-2 proteins in liver tissues of different groups Data are represented as x±s, n=3. *P<0.05, **P<0.01, vs control group; △P<0.05, △△P<0.01, vs rosiglitazone group. NOR: Normal group; CON: Control group; ROS: Rosiglitazone group; FEN: Fenofibrate group; UA300: High-dose ursolic acid (300 mL/(kg·d)) group; UA150: low-dose ursolic acid (150 mL/(kg·d)) group. PEPCK: phosphoenolpyruvate carboxykinase; GLUT-2: glucose transport factor-2; IRS-2: insulin receptor substrate-2."

Table 2

Expressions of PEPCK, IRS-2 and GLUT-2 mRNAs in liver tissues of each group (x±s, %)"

Group n PEPCK GLUT-2 IRS-2
Normal 7 10.86±1.15** 15.04±0.88** 5.41±0.57**
Control 7 18.37±1.29△△ 10.20±1.49 1.23±0.34
Rosiglitazone 7 12.45±1.26** 11.63±0.83 1.63±0.17
Fenofibrate 6 15.97±1.47 13.59±0.95 1.34±0.12
UA 300 mL/(kg·d) 7 13.02±0.95**△ 11.15±1.33 2.38±0.27
UA 150 mL/(kg·d) 6 14.18±0.92* 12.72±1.09 2.39±0.21

Table 3

Expressions of PPARα and PPARγ proteins observed by quantitative immunohistochemical staining in liver tissues of each group (x±s)"

Group n PPARα PPARγ
Normal 3 3.73±0.21** 2.78±0.13
Control 3 1.53±0.15▲▲ 2.61±0.36
Rosiglitazone 3 1.84±0.26 3.04±0.21
Fenofibrate 3 2.21±0.27**△△ 3.13±0.38
UA 300 mL/(kg·d) 3 3.10±0.34**△△ 2.72±0.07
UA 150 mL/(kg·d) 3 3.07±0.22**△△ 3.06±0.31

Figure 2

Expressions of PPARα and PPARγ proteins detected by immunohistochemical method in liver tissues of different groups (Light microscopy, ×250) NOR: Normal group; CON: Control group; ROS: Rosiglitazone group; FEN: Fenofibrate group; UA300: High-dose ursolic acid (300 mL/(kg·d)) group; UA150: low-dose ursolic acid (150 mL/(kg·d)) group. PPAR: peroxisome proliferator-activated receptor."

[1] Zhang J, Wu SY, Wang L, Wang GL, Zhu DZ . Effects of ursolic acid on fat metabolism in high-fat-fed induced insulin resistance rats[J]. Zhonghua Zhong Yi Yao Xue Kan, 2010,28(5):975-978
张杰, 吴淑艳, 王琳, 王冠梁, 朱德增 . 熊果酸对高脂饮食诱导胰岛素抵抗大鼠脂质代谢的影响[J]. 中华中医药学刊, 2010,28(5):975-978
[2] Enomoto N, Takei Y, Hirose M, Konno A, Shibuya T, Matsuyama S, Suzuki S, Kitamura KI, Sato N . Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-gamma, pioglitazone[J]. J Pharmacol Exp Ther, 2003,306(3):846-854
doi: 10.1124/jpet.102.047217
[3] Chen CC, Hsu CY, Chen CY, Liu HK . Fructus Corni suppresses hepatic gluconeogenesis related gene transcription, enhances glucose responsiveness of pancreatic beta-cells, and prevents toxin induced beta-cell death[J]. J Ethnopharmacol, 2008,117(3):483-490
doi: 10.1016/j.jep.2008.02.032
[4] Wu S, Lu FE . Role of insulin receptor substrate 2 in pancreatic β-cell[J]. Guo Ji Nei Fen Mi Dai Xie Za Zhi, 2009,29(5):349-350, 353
邬姗, 陆付耳 . 胰岛素受体底物-2对胰岛β细胞的作用[J]. 国际内分泌代谢杂志, 2009,29(5):349-350, 353
[5] Chen SQ, Li H, Liu Q . The effect of high-fat diet on IRS-1 and IRS-2 expression of fatty liver in rat[J]. Zhongguo Tang Niao Bing Za Zhi, 2008,16(7):409-412
陈世清, 黎华, 刘杞 . 高脂饮食对大鼠脂肪肝胰岛素受体底物1、2表达的影响[J]. 中国糖尿病杂志, 2008,16(7):409-412
[6] Wang SH, Wang WJ . Pathogenesis of insulin resistance and prevention and treatment strategy of integrated traditional Chinese and Western medicine[J]. J Chin Integr Med, 2004,2(1):14-16
doi: 10.3736/jcim20040106
王树海, 王文健 . 胰岛素抵抗的发病机制及中西医结合防治策略[J]. 中西医结合学报, 2004,2(1):14-16
doi: 10.3736/jcim20040106
[7] He YM, Wang WJ, Chen WH, Ying J . Effects of Pollen Typhae total flavones on mRNA expressions of peroxisome proliferator-activated receptors in 3T3-L1 adipocytes[J]. J Chin Integr Med, 2008,6(9):939-941
何燕铭, 王文健, 陈伟华, 应健 . 蒲黄总黄酮对3T3-L1脂肪细胞过氧化物酶体增生物激活受体家族mRNA基因表达的影响[J]. 中西医结合学报, 2008,6(9):939-941
[1] Mohadeseh Ostovar, Abolfazl Akbari, Mohammad Hossein Anbardar, Aida Iraji, Mohsen Salmanpour, Salar Hafez Ghoran, Mojtaba Heydari, Mesbah Shams. Effects of Citrullus colocynthis L. in a rat model of diabetic neuropathy. Journal of Integrative Medicine, 2020, 18(1): 59-67.
[2] Yi Ran Hu, San Li Xing, Chuan Chen, Ding Zhu Shen, Jiu Lin Chen. Tiaoxin Recipe, a Chinese herbal formula, inhibits microRNA-34a expression in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease. Journal of Integrative Medicine, 2019, 17(6): 404-409.
[3] Sonia Chew Wen Phang, Uma Devi Palanisamy, Khalid Abdul Kadir. Effects of geraniin (rambutan rind extract) on blood pressure and metabolic parameters in rats fed high-fat diet. Journal of Integrative Medicine, 2019, 17(2): 100-106.
[4] Bérénice Colleville, Nicolas Perzo, Guillaume Avinée, Anaïs Dumesnil, Frederic Ziegler, Paul Billoir, Hélène Eltchaninoff, Vincent Richard, Eric Durand. Impact of high-fat diet and vitamin D3 supplementation on aortic stenosis establishment in waved-2 epidermal growth factor receptor mutant mice. Journal of Integrative Medicine, 2019, 17(2): 107-114.
[5] Mehranghiz Ebrahimi-Mameghani, Mohammad Asghari-Jafarabadi, Khatereh Rezazadeh. TCF7L2-rs7903146 polymorphism modulates the effect of artichoke leaf extract supplementation on insulin resistance in metabolic syndrome: A randomized, double-blind, placebo-controlled trial. Journal of Integrative Medicine, 2018, 16(5): 329-334.
[6] Olakunle Bamikole Afolabi, Omotade Ibidun Oloyede, Shadrack Oludare Agunbiade. Inhibitory potentials of phenolic-rich extracts from Bridelia ferruginea on two key carbohydrate-metabolizing enzymes and Fe2+-induced pancreatic oxidative stress. Journal of Integrative Medicine, 2018, 16(3): 192-198.
[7] Chun-song Hu, Tengiz Tkebuchava. SEEDi1.0-3.0 strategies for major noncommunicable diseases in China. Journal of Integrative Medicine, 2017, 15(4): 265-269.
[8] Uduak Akpan Okon, Idorenyin Udo Umoren. Comparison of antioxidant activity of insulin, Ocimum gratissimum L., and Vernonia amygdalina L. in type 1 diabetic rat model. Journal of Integrative Medicine, 2017, 15(4): 302-309.
[9] Nazli Samadi, Hassan Mozaffari-Khosravi, Masoud Rahmanian, Mohsen Askarishahi. Effects of bee propolis supplementation on glycemic control, lipid profile and insulin resistance indices in patients with type 2 diabetes: A randomized, double-blind clinical trial. Journal of Integrative Medicine, 2017, 15(2): 124-134.
[10] Bhesh Raj Sharma, Dong Wook Kim, Dong Young Rhyu. Korean Chungtaejeon tea extract attenuates weight gain in C57BL/6J-Lep ob/ob mice and regulates adipogenesis and lipolysis in 3T3-L1 adipocytes. Journal of Integrative Medicine, 2017, 15(1): 56-63.
[11] Yee Chi Peggy Wong. Need of integrated dietary therapy for persons with diabetes mellitus and “unhealthy” body constitution presentations. Journal of Integrative Medicine, 2016, 14(4): 255-268.
[12] Ausanee Wanchai, Duangjai Phrompayak. Use of complementary and alternative medicine among Thai patients with type 2 diabetes mellitus. Journal of Integrative Medicine, 2016, 14(4): 297-305.
[13] Sulaiman Al-Eidi, SalwaTayel, Fatima Al-Slail, Naseem Akhtar Qureshi, Imen Sohaibani, Mohamed Khalil, Abdullah Mohammad Al-Bedah. Knowledge, attitude and practice of patients with type 2 diabetes mellitus towards complementary and alternative medicine. Journal of Integrative Medicine, 2016, 14(3): 187-196.
[14] Mohammad Hashem Hashempur, Mojtaba Heydari, Seyed Hamdollah Mosavat, Seyyed Taghi Heydari, Mesbah Shams. Complementary and alternative medicine use in Iranian patients with diabetes mellitus. Journal of Integrative Medicine, 2015, 13(5): 319-325.
[15] Shi-li Jiang, Xu-dong Hu, Ping Liu. Immunomodulation and liver protection of Yinchenhao decoction against concanavalin A-induced chronic liver injury in mice. Journal of Integrative Medicine, 2015, 13(4): 262-268.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[2] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[3] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[4] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[5] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022
[6] Bing Hu , Hong-mei An , Ke-ping Shen , Qin Du. Senescence-inducing effects of Chinese herbal medicine Tenglong Buzhong Decoction on human colon carcinoma LS-174-T cells and the mechanism. Journal of Chinese Integrative Medicine, 2010, 8(11): 1048-1052
[7] Ya-bing Zhou, Jian-er Yu, Jie Wu, Li Bai, Li-li Huo, Xin-guang Zhang, Li-qing Li . Effects of Chinese herbal medicine Bushen Gubiao Recipe on toll-like receptor 4 and CD4 +CD25 +foxp3 +regulatory T cells in mice with recurrent respiratory tract infections. Journal of Chinese Integrative Medicine, 2010, 8(11): 1053-1059
[8] Chan Chen, Yong-mei Meng , Peng Zhang, Juan Wang, Hui-hui Zhao, Shu-zhen Guo , Wei Wang. Diagnosis and treatment rule of traditional Chinese medicine for syndrome factors of chronic congestive heart failure: a study based on Shannon entropy method. Journal of Chinese Integrative Medicine, 2010, 8(11): 1080-1084
[9] Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[10] Liang-ping Hu, Xiao-lei Bao. Three-factor designs unable to examine the interactions (Part 2). Journal of Chinese Integrative Medicine, 2012, 10(11): 1229-1232